Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Drug Resistance

Free Subscription Articles published in J Virol Retrieve available abstracts of 40 articles: HTML format

Single Articles

May 2009
1. IBARRA KD , Pfeiffer JK
   Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.
   J Virol. 2009;83:4538-47.
   PubMed     Related articles    Abstract available
   
   
   March 2009
2. ADAMSON CS , Waki K, Ablan SD, Salzwedel K, et al
   IMPACT OF HUMAN IMMUNODEFICIENCY VRIUS TYPE 1 RESISTANCE TO PROTEASE INHIBITORS ON EVOLUTION OF RESISTANCE TO THE MATURATION INHIBITOR BEVIRIMAT (PA-457).
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. DUDLEY DM , Wentzel JL, Lalonde MS, Veazey RS, et al
   Selection of SHIV resistant to a vaginal microbicide in macaques.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   February 2009
4. ARMSTRONG KL , Lee TH, Essex M
   Replicative Capacity Differences of Thymidine Analog Resistance Mutations in Subtype B and C HIV-1.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
5. NOLAN KM , Del Prete GQ, Jordan AP, Haggarty B, et al
   Characterization of an HIV-1 V3 Deletion Mutation that Confers Resistance to CCR5 Inhibitors and the Ability to Use Aplaviroc-Bound Receptor.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
6. AMBROSE Z , Herman BD, Sheen CW, Zelina S, et al
   The human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase inhibitor resistance mutation I132M confers hypersensitivity to nucleoside analogs.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
7. SOLMONE M , Vincenti D, Prosperi MC, Bruselles A, et al
   Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen.
   J Virol. 2009;83:1718-26.
   PubMed     Related articles    Abstract available
   
   
   January 2009
8. AOKI M , Venzon DJ, Koh Y, Aoki-Ogata H, et al
   Non-cleavage Site Gag Mutations in Amprenavir-resistant HIV-1 Predispose HIV-1 to Rapid Acquisition of Amprenavir Resistance But Delays Development of Resistance to Other Protease Inhibitors.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
9. HUE S , Gifford RJ, Dunn D, Fernhill E, et al
   Demonstration of Sustained Drug-Resistant HIV-1 Lineages Circulating amongst Treatment-Naive Individuals.
   J Virol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
10. RAY N , Blackburn LA, Doms RW
    HR-2 Mutations in HIV-1 gp41 Restore Fusion Kinetics Delayed by HR-1 Mutations that Cause Clinical Resistance to Enfuvirtide.
    J Virol. 2009.
    PubMed     Related articles    Abstract available
    
    
    November 2008
11. PAREDES R , Sagar M, Marconi VC, Hoh R, et al
    In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant HIV-1 in the Absence of Lamivudine.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
12. YORK J , Dai D, Amberg SM, Nunberg JH, et al
    pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors.
    J Virol. 2008;82:10932-9.
    PubMed     Related articles    Abstract available
    
    
    September 2008
13. HARRISON JE , Lynch JB, Sierra LJ, Blackburn LA, et al
    Baseline resistance of primary HIV-1 strains to the CXCR4 inhibitor AMD3100.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
14. MOSEBI S , Morris L, Dirr HW, Sayed Y, et al
    Active Site Mutations in the South African HIV-1 Subtype C Protease Impact Significantly on Clinical Inhibitor Binding: a Kinetic and Thermodynamic Study.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    August 2008
15. MITSUYA Y , Varghese V, Wang C, Liu TF, et al
    Minority HIV-1 Variants in Antiretroviral Naive Persons with Reverse Transcriptase Codon 215 Revertant Mutations.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
16. GOETHALS O , Clayton R, Van Ginderen M, Vereycken I, et al
    Resistance mutations in HIV-1 integrase selected with Elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
17. BOUVIER NM , Lowen AC, Palese P
    Oseltamivir-Resistant Influenza A Viruses Transmit Efficiently Among Guinea Pigs by Direct Contact but not by Aerosol.
    J Virol. 2008.
    PubMed     Related articles    Abstract available
    
    
    July 2008
18. MYERS RE , Pillay D
    Analysis of Natural Sequence Variation and Covariation in Human Immunodeficiency Virus Type-1 Integrase.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    June 2008
19. MARTINS AN , Medeiros SO, Simonetti JP, Schatzmayr HG, et al
    Phylogenetic and genetic analysis of Feline Immunodeficiency Virus gag, pol and env genes from domestic cats under NRTI treatment or treatment-naive circulating in Rio de Janeiro, Brazil.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    May 2008
20. TSIBRIS AM , Sagar M, Gulick RM, Su Z, et al
    In vivo emergence of vicriviroc resistance in an HIV-1 subtype C-infected subject.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. DE PALMA AM , Heggermont W, Lanke K, Coutard B, et al
    The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.
    J Virol. 2008;82:4720-30.
    PubMed     Related articles    Abstract available
    
    
    April 2008
22. EGGINK D , Baldwin CE, Deng Y, Langedijk JP, et al
    Selection of T1249-resistant Human Immunodeficiency Virus type 1 variants.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. KOZISEK M , Saskova KG, Rezacova P, Brynda J, et al
    Ninety Nine is Not Enough: Molecular Characterization of Inhibitor Resistant HIV-1 Protease Mutants with Insertions in the Flap Region.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. YANG F , Robotham JM, Nelson HB, Irsigler A, et al
    Cyclophilin A is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine A Resistance In Vitro.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
25. LITTLE SJ , Frost SD, Wong JK, Smith DM, et al
    The Persistence of Transmitted Drug Resistance among Subjects with Primary HIV Infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
26. HACHIYA A , Kodama EN, Sarafianos SG, Schuckmann MM, et al
    Amino Acid Mutation N348I in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Multi-class Resistance to Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitors.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
27. GRAY ES , Moore PL, Bibollet-Ruche F, Li H, et al
    4E10 Resistant Variants in an HIV-1 Subtype C Infected Individual with an Anti-MPER Neutralizing Antibody Response.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
28. WATHELET MG , Orr M, Frieman MB, Baric RS, et al
    Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.
    J Virol. 2007;81:11620-33.
    PubMed     Related articles    Abstract available
    
    
    October 2007
29. SHIMURA K , Kodama E, Sakagami Y, Matsuzaki Y, et al
    Broad Anti-Retroviral Activity and Resistance Profile of a Novel Human Immunodeficiency Virus Integrase Inhibitor, Elvitegravir (JTK-303/GS-9137).
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. CHOU S , Marousek GI
    Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
31. ADAMIAK B , Ekblad M, Bergstrom T, Ferro V, et al
    Herpes Simplex Virus Type 2 Glycoprotein G is Targeted by the Sulfated Oligo- and Polysaccharide Inhibitors of the Virus Attachment to Cells.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. DENG L , Dai P, Ciro A, Smee DF, et al
    Identification of novel antipoxviral agents: Mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. DIERYNCK I , De Wit M, Gustin E, Keuleers I, et al
    Binding kinetics of darunavir to HIV-1 protease explain the potent antiviral activity and high genetic barrier.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
34. YEN HL , Ilyushina NA, Salomon R, Hoffmann E, et al
    Neuraminidase Inhibitor Resistant Recombinant A/Vietnam/1203/04 (H5N1) Influenza Viruses Retain Their Replication Efficiency and Pathogenicity in Vitro and in Vivo.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. AMBROSE Z , Palmer S, Boltz VF, Kearney M, et al
    Suppression of Viremia and Evolution of HIV-1 Drug Resistance in a Macaque Model for Antiretroviral Therapy.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
36. BROCKMAN MA , Schneidewind A, Lahaie M, Schmidt A, et al
    Escape and compensation from early HLA-B57-mediated CTL pressure on HIV-1 Gag alters capsid interactions with cyclophilin A.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. MEHANDRU S , Vcelar B, Wrin T, Stiegler G, et al
    Adjunctive passive immunotherapy in HIV-1-infected individuals treated with antiviral therapy during acute/early infection.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. CECCHERINI-SILBERSTEIN F , Svicher V, Sing T, Artese A, et al
    Characterization and Structural Analysis of Novel Mutations in HIV-1 Reverse Transcriptase Involved in the Regulation of Resistance to Non-Nucleoside Inhibitors.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
39. BUONAGURO L , Tornesello ML, Buonaguro FM
    HIV-1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. LIN G , Bertolotti-Ciarlet A, Haggarty B, Romano J, et al
    Replication competent variants of human immunodeficiency virus type-2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists.
    J Virol. 2007;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: